Radnet, Inc. (RDNT) fundamentals score
Radnet is a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. It has been in business since 1985. Its principal business segment is the provision of diagnostic imaging services.
Services-Medical Laboratories · Healthcare · Listed on NASDAQ
Overall: 5.7 out of 10, Mixed fundamentals
- Growth: 5.6/10
- Profitability: 4.7/10
- Financial health: 4.3/10
- Earnings quality: 8.2/10
- Valuation: 7.1/10
Scores are calculated from Radnet, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10